Abstract

Hashimoto’s thyroiditis is the most common autoimmune thyroid disorder, yet the initial trigger that exposes thyroid antigens such as Thyroid Peroxidase (TPO) to the immune system remains unclear. This article proposes a novel anatomical hypothesis suggesting that the presence of the Thyroid Ima Artery (TIA)—a rare vascular variant—may contribute to early mechanical disruption of thyroid tissue, allowing intracellular components like TPO to enter the bloodstream. We explore the potential role of TIA in increasing local vascular pressure or fragility in the thyroid isthmus, leading to microdamage in follicular cells. Such exposure may initiate or accelerate the autoimmune cascade in genetically predisposed individuals. A research methodology is proposed to test this hypothesis through imaging, histopathology, and population-based studies. If validated, this theory could provide a new perspective on the etiology of Hashimoto’s thyroiditis and the influence of vascular anomalies on autoimmune disease onset.

Keywords: Breastfeeding promotion program; Breastfeeding self-efficacy; Primigravid mothers.

Introduction

Hashimoto’s thyroiditis is the most common autoimmune thyroid disorder, characterized by chronic lymphocytic infiltration and progressive destruction of the thyroid gland. Despite decades of investigation into its immunological and genetic underpinnings, the precise initial triggers that expose thyroid antigens—particularly Thyroid Peroxidase (TPO)—to the immune system remain elusive.

In this article, we propose a novel anatomical hypothesis: the presence of the Thyroid IMA Artery (TIA), a rare vascular variant, may contribute to microstructural stress in the thyroid gland, particularly at the isthmus. This localized disruption may facilitate the leakage of TPO into the interstitial space or bloodstream, triggering an autoimmune response in genetically predisposed individuals.

The thyroid IMA artery: Anatomy and variability

The TIA is an anatomical variant found in approximately 3% to 10% of individuals [1]. It most commonly arises from the brachiocephalic trunk, but may also originate from the aortic arch, right common carotid, subclavian, or internal thoracic artery. When present, the TIA usually travels anterior to the trachea, supplying the inferior thyroid or isthmus.

This artery often compensates for a hypoplastic or absent inferior thyroid artery and may penetrate thyroid tissue more centrally. Because of its variable origin and trajectory, it can create areas of altered hemodynamic stress, especially in the thin or metabolically active central regions of the gland [2].

Though traditionally discussed in the context of surgical risk, its anatomical characteristics suggest it may also influence thyroid microenvironment dynamics—an aspect that has been largely overlooked in autoimmune thyroid research.

Hypothetical model: TPO exposure via vascular-induced microdamage

Under normal physiology, TPO remains confined to the apical membrane of thyroid follicular cells and is not exposed to immune surveillance [3]. However, structural stress caused by the presence or pulsatile force of the TIA may compromise the integrity of these follicles.

The mechanical stress from the artery’s proximity and pressure, especially in the central thyroid, may cause microtrauma—subclinical damage that allows TPO and other intracellular components to leak into the interstitial space and, eventually, the bloodstream.

This breach of anatomical compartmentalization creates the opportunity for immune cells to encounter and process TPO as an antigen, particularly in the context of genetic susceptibility. While not the sole cause of Hashimoto’s thyroiditis, this vascular-induced disruption may act as a physical trigger in the autoimmune cascade.

Immune activation pathway

Following antigen leakage, dendritic cells in the interstitial space may capture and process TPO, migrating to nearby lymph nodes. There, TPO peptides are presented to naïve CD4+ T cells. In genetically predisposed individuals (e.g., HLA-DR3/DR5), this can trigger a Th1/Th17-mediated immune response [4].

Activated T cells return to the thyroid, where they orchestrate further immune activity, including B cell activation and antibody production. Anti-TPO antibodies—diagnostic of Hashimoto’s thyroiditis—may participate in tissue destruction via complement activation or ADCC [7].

Over time, the inflammatory response becomes chronic. Cytokines like IFN-γ and TNF-α perpetuate follicular cell damage, leading to fibrosis and irreversible loss of thyroid function [6].

Implications for research and clinical practice

The proposed role of the TIA in initiating or facilitating thyroid autoimmunity presents several testable hypotheses:

Imaging studies: Use of high-resolution ultrasound or angiography to compare vascular anatomy in Hashimoto’s patients versus controls.

Histopathological analysis: Examining thyroidectomy specimens for proximity of vascular structures to damaged follicles.

Prospective cohort studies: Monitoring individuals with TIA for emergence of anti-TPO antibodies.

Surgical and diagnostic integration: Recognizing the presence of TIA as a potential biomarker of autoimmune risk.

By integrating vascular anatomy into models of autoimmune initiation, this hypothesis may not only provide new insight into Hashimoto’s thyroiditis but also stimulate broader investigation into how anatomical variants influence disease vulnerability.

Proposed research studies

To test the vascular hypothesis of Hashimoto’s thyroiditis, the following studies are proposed:

Imaging-based anatomical study

Objective: Determine the prevalence of the TIA in patients with Hashimoto’s thyroiditis compared to healthy controls.

Method: Use high-resolution Doppler ultrasound, CT angiography, or MR angiography to assess for TIA presence, artery diameter, and relation to thyroid damage.

Expected outcome: Higher TIA prevalence or damage correlation in Hashimoto’s group.

Histopathological correlation study

Objective: Examine thyroid tissue specimens to correlate TIA proximity with immune infiltration and follicular damage.

Method: Use thyroidectomy samples stained for immune cells and vascular markers.

Expected outcome: Greater immune infiltration near vascular structures.

Longitudinal cohort study

Objective: Track autoimmune thyroid disease onset in individuals with known TIA.

Method: Screen for TIA presence, measure anti-TPO levels, and follow participants over time.

Expected outcome: Increased autoimmune incidence in TIA-positive individuals.

Optional experimental model

Develop a 3D thyroid tissue model to simulate mechanical stress from vascular flow and assess TPO leakage and immune activation in vitro.

Conclusion

Hashimoto’s thyroiditis is a multifactorial autoimmune disease, but the question of initial antigen exposure remains open. The thyroid ima artery, though rarely present, may be a subtle contributor to the breach of immune tolerance via structural microdisruption of the thyroid parenchyma.

Future investigations combining imaging, immunology, and histology will be essential to test this hypothesis. Should evidence support a link between vascular anatomy and autoimmune susceptibility, the findings may open new strategies for early detection, prevention, and understanding of thyroid autoimmunity.

References

1. Standring S, editor. Gray’s Anatomy: The Anatomical Basis of Clinical Practice. 42nd ed. Elsevier Health Sciences. 2020.
2. Oslen WR, Rogalski TT. The thyroid ima artery: A surgical consideration. Arch Surg. 1977; 112: 1102–4.
3. McLachlan SM, Rapoport B. Breaking tolerance to thyroid antigens: Changing concepts in thyroid autoimmunity. Endocr Rev. 2007; 28: 595–605.
4. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmun Rev. 2014; 13: 391–7.
5. Orellana P, López P, Valenzuela CY. A possible vascular cause for autoimmune diseases: Vascular and lymphatic anatomy may determine the site of immune attack. Med Hypotheses. 2015; 85: 287–91.
6. Bossowski A, Moniuszko M, Dąbrowska M, et al. Analysis of T regulatory cells and CD4+ CD161+ T cells in the peripheral blood of young patients with Hashimoto’s thyroiditis: The impact of thyroid function and treatment. Horm Res Paediatr. 2013; 79: 403–11.
7. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003; 348: 2646–55.